The Pharma Patent Cliff Explained: What It Is and How Companies Navigate It

In the coming years, about 200 drugs will have their patents or terms of exclusivity come to an end. These drugs make up an estimated $400 billion in revenue for the pharma industry. While this isn’t the first patent cliff to hit the industry, it is the largest its ever faced.